Literature DB >> 2017227

Preoperative transcatheter closure of congenital muscular ventricular septal defects.

N D Bridges1, S B Perry, J F Keane, S A Goldstein, V Mandell, J E Mayer, R A Jonas, A R Casteneda, J E Lock.   

Abstract

BACKGROUND: Surgical repair of muscular ventricular septal defects, particularly those associated with complex heart lesions carries a higher risk of reoperation and death than the repair of membranous defects. Closing a muscular defect through an incision in the systemic ventricle may cause late ventricular dysfunction. In a collaborative approach to this problem, we undertook preoperative transcatheter closure of muscular ventricular septal defects remote from the atrioventricular and semilunar valves, followed by the surgical repair of associated conditions.
METHODS: In 12 patients selected jointly by a cardiologist and a cardiac surgeon, we attempted preoperative transcatheter umbrella closure of 21 defects. Half the patients had associated complex heart lesions; the others had had pulmonary-artery banding to reduce the amount of left-to-right shunting. Half had severe ventricular septal deficiency.
RESULTS: All 21 defects were successfully closed without major complications. Subsequent cardiac surgery for associated conditions in 11 of the 12 patients resulted in a mean pulmonary-to-systemic flow ratio of 1.1, indicating minimal residual left-to-right shunting; 1 patient awaited surgical repair. No deaths, reoperations, or late complications have occurred after a follow-up of 7 to 20 months.
CONCLUSIONS: A collaborative approach using transcatheter closure followed by the surgical repair of associated cardiac lesions may decrease rates of operative mortality, reoperation, and left ventricular dysfunction in patients with muscular ventricular septal defects.

Entities:  

Mesh:

Year:  1991        PMID: 2017227     DOI: 10.1056/NEJM199105093241903

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  22 in total

1.  Ventricular Septal Defect.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-12

Review 2.  Catheter closure of perimembranous/membranous ventricular septal defects using the Amplatzer occluder device.

Authors:  B D Thanopoulos
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

Review 3.  Catheter closure of congenital muscular ventricular septal defects.

Authors:  B D Thanopoulos
Journal:  Pediatr Cardiol       Date:  2005 May-Jun       Impact factor: 1.655

4.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: shunt lesions.

Authors:  Candice K Silversides; Annie Dore; Nancy Poirier; Dylan Taylor; Louise Harris; Matthias Greutmann; Lee Benson; Helmut Baumgartner; David Celermajer; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

Review 5.  Non surgical treatment in congenital heart disease.

Authors:  S Radhakrishnan; S Shrivastava
Journal:  Indian J Pediatr       Date:  1998 Mar-Apr       Impact factor: 1.967

6.  Outcome of transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder.

Authors:  B D Thanopoulos; M L Rigby
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

7.  Interventional VSD-Closure with the Nit-Occlud® Lê VSD-Coil in 110 Patients: Early and Midterm Results of the EUREVECO-Registry.

Authors:  Nikolaus A Haas; Laura Kock; Harald Bertram; Regina Boekenkamp; Daniel De Wolf; Igor Ditkivskyy; Matthias W Freund; Marc Gewillig; Christoph M Happel; Ulrike Herberg; Edvard Karthasyan; Rainer Kozlik-Feldmann; Oliver Kretschmar; Yulia Kuzmenko; Ornella Milanesi; Goetz Mueller; Giacomo Pongiglione; Stephan Schubert; Gleb Tarusinov; Christoph Kampmann
Journal:  Pediatr Cardiol       Date:  2016-11-15       Impact factor: 1.655

8.  Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in children.

Authors:  B D Thanopoulos; G S Tsaousis; E Karanasios; N G Eleftherakis; C Paphitis
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

9.  Transcatheter device closure of perimembranous ventricular septal defects: mid-term outcomes.

Authors:  Jian Yang; Lifang Yang; Yi Wan; Jian Zuo; Jun Zhang; Wensheng Chen; Jun Li; Lijun Sun; Shiqiang Yu; Jincheng Liu; Tao Chen; Weixun Duan; Lize Xiong; Dinghua Yi
Journal:  Eur Heart J       Date:  2010-08-27       Impact factor: 29.983

10.  Transcatheter closure of interatrial communications with a modified umbrella device.

Authors:  A N Redington; M L Rigby
Journal:  Br Heart J       Date:  1994-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.